University of Geneva uses the FlexStation 3 and SpectraMax readers for assay development and screening

University of Geneva, Readers, Assay Development and Screening Unit, Faculty of Medicine

M. Yves Camet, Researcher

SpectraMax Paradigm Multi-Mode Microplate Reader

FlexStation 3 Multi-Mode Microplate Reader

SpectraMax L Microplate Reader

The Challenge

 M. Yves Cambet is a researcher within the Readers, Assay Development & Screening (RE.A.D.S) Unit at the Faculty of Medicine in the Centre Medical Univerisitaire (C.M.U.) of Geneva, Switzerland. The main objectives of the RE.A.D.S Unit are to provide expertise in assay development and screening to all scientists within the faculty. The group support a wide range of assays, from enzymatic target to cell-based assays, in both 96- and 384- well formats.

University of Geneva usesFlexStation 3 and SpectraMax

The Solution

To support this vital work, researchers use a variety of state-of-the-art microplate readers, including: the FlexStation® 3 Multi-Mode Microplate Reader for ion channel assays such as membrane potential or calcium assays, the SpectraMax® L Microplate Reader for all luciferase-based assays, the SpectraMax® Paradigm Multi-Mode Microplate Reader for a wide range of other assays such as ELISA, cytotoxicity, Bradford, cell viability assays, etc.

Two of these readers are equipped with a system of injection which allows scientists to measure several wells simultaneously in kinetic mode. By analysing all their data in the SoftMax® Pro Data Acquisition and Analysis Software, Yves is able to provide support for the calculation of pharmacological parameters such as IC50, Emax, Km, Kd, etc.

Ready to get started?

We are ready to help you solve your tough research challenges. Our proven solutions and highly qualified teams across the globe can help advance your next big discovery.